These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
415 related articles for article (PubMed ID: 29066891)
1. Enhanced anticancer activity and oral bioavailability of ellagic acid through encapsulation in biodegradable polymeric nanoparticles. Mady FM; Shaker MA Int J Nanomedicine; 2017; 12():7405-7417. PubMed ID: 29066891 [TBL] [Abstract][Full Text] [Related]
2. Development of biodegradable nanoparticles for oral delivery of ellagic acid and evaluation of their antioxidant efficacy against cyclosporine A-induced nephrotoxicity in rats. Sonaje K; Italia JL; Sharma G; Bhardwaj V; Tikoo K; Kumar MN Pharm Res; 2007 May; 24(5):899-908. PubMed ID: 17377747 [TBL] [Abstract][Full Text] [Related]
3. Poly(ε-benzyloxycarbonyl-L-lysine)-grafted branched polyethylenimine as efficient nanocarriers for indomethacin with enhanced oral bioavailability and anti-inflammatory efficacy. Lu C; Li X; Xia W; Lu S; Luo H; Ye D; Zhang Y; Liu D Acta Biomater; 2017 Feb; 49():434-443. PubMed ID: 27867110 [TBL] [Abstract][Full Text] [Related]
4. Preparation and in vivo pharmacokinetics of curcumin-loaded PCL-PEG-PCL triblock copolymeric nanoparticles. Feng R; Song Z; Zhai G Int J Nanomedicine; 2012; 7():4089-98. PubMed ID: 22888245 [TBL] [Abstract][Full Text] [Related]
6. Ellagic acid encapsulated chitosan nanoparticles for drug delivery system in human oral cancer cell line (KB). Arulmozhi V; Pandian K; Mirunalini S Colloids Surf B Biointerfaces; 2013 Oct; 110():313-20. PubMed ID: 23732810 [TBL] [Abstract][Full Text] [Related]
8. Daunorubicin oral bioavailability enhancement by surface coated natural biodegradable macromolecule chitosan based polymeric nanoparticles. Ahmad N; Ahmad R; Alam MA; Ahmad FJ; Amir M; Pottoo FH; Sarafroz M; Jafar M; Umar K Int J Biol Macromol; 2019 May; 128():825-838. PubMed ID: 30690115 [TBL] [Abstract][Full Text] [Related]
9. Cyclodextrin-based nanosponge for improvement of solubility and oral bioavailability of Ellagic acid. Mady FM; Ibrahim SR Pak J Pharm Sci; 2018 Sep; 31(5(Supplementary)):2069-2076. PubMed ID: 30393214 [TBL] [Abstract][Full Text] [Related]
10. Ethyl cellulose nanoparticles as a platform to decrease ulcerogenic potential of piroxicam: formulation and in vitro/in vivo evaluation. El-Habashy SE; Allam AN; El-Kamel AH Int J Nanomedicine; 2016; 11():2369-80. PubMed ID: 27307735 [TBL] [Abstract][Full Text] [Related]
11. Poly(vinyl methyl ether/maleic anhydride)-Doped PEG-PLA Nanoparticles for Oral Paclitaxel Delivery To Improve Bioadhesive Efficiency. Wang Q; Li C; Ren T; Chen S; Ye X; Guo H; He H; Zhang Y; Yin T; Liang XJ; Tang X Mol Pharm; 2017 Oct; 14(10):3598-3608. PubMed ID: 28892400 [TBL] [Abstract][Full Text] [Related]
12. Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel. Feng SS; Mei L; Anitha P; Gan CW; Zhou W Biomaterials; 2009 Jul; 30(19):3297-306. PubMed ID: 19299012 [TBL] [Abstract][Full Text] [Related]
13. Oral delivery of indinavir using mPEG-PCL nanoparticles: preparation, optimization, cellular uptake, transport and pharmacokinetic evaluation. Kurd M; Sadegh Malvajerd S; Rezaee S; Hamidi M; Derakhshandeh K Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):2123-2133. PubMed ID: 31155961 [No Abstract] [Full Text] [Related]
14. Enhanced oral bioavailability of the antiretroviral efavirenz encapsulated in poly(epsilon-caprolactone) nanoparticles by a spray-drying method. Tshweu L; Katata L; Kalombo L; Chiappetta DA; Hocht C; Sosnik A; Swai H Nanomedicine (Lond); 2014; 9(12):1821-33. PubMed ID: 24364871 [TBL] [Abstract][Full Text] [Related]
15. A potential in situ gel formulation loaded with novel fabricated poly(lactide-co-glycolide) nanoparticles for enhancing and sustaining the ophthalmic delivery of ketoconazole. Ahmed TA; Aljaeid BM Int J Nanomedicine; 2017; 12():1863-1875. PubMed ID: 28331311 [TBL] [Abstract][Full Text] [Related]
16. Enhancement of atorvastatin oral bioavailability via encapsulation in polymeric nanoparticles. Shaker MA; Elbadawy HM; Al Thagfan SS; Shaker MA Int J Pharm; 2021 Jan; 592():120077. PubMed ID: 33246047 [TBL] [Abstract][Full Text] [Related]
17. Enhancing the Bioavailability of the Ellagitannin, Geraniin: Formulation, Characterization, and in vivo Evaluation. Elendran S; Shiva Kumar V; Sundralingam U; Tow WK; Palanisamy UD Int J Pharm; 2024 Jul; 660():124333. PubMed ID: 38866080 [TBL] [Abstract][Full Text] [Related]
18. Preparation and characterization of letrozole-loaded poly(d,l-lactide) nanoparticles for drug delivery in breast cancer therapy. Alemrayat B; Elhissi A; Younes HM Pharm Dev Technol; 2019 Feb; 24(2):235-242. PubMed ID: 29561210 [TBL] [Abstract][Full Text] [Related]
19. Biodegradable in situ gelling system for subcutaneous administration of ellagic acid and ellagic acid loaded nanoparticles: evaluation of their antioxidant potential against cyclosporine induced nephrotoxicity in rats. Sharma G; Italia JL; Sonaje K; Tikoo K; Ravi Kumar MN J Control Release; 2007 Mar; 118(1):27-37. PubMed ID: 17258836 [TBL] [Abstract][Full Text] [Related]
20. Physical PEGylation Enhances The Cytotoxicity Of 5-Fluorouracil-Loaded PLGA And PCL Nanoparticles. Ashour AE; Badran M; Kumar A; Hussain T; Alsarra IA; Yassin AEB Int J Nanomedicine; 2019; 14():9259-9273. PubMed ID: 31819428 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]